Northwestern Mutual Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-255	Closed	-$7.22K	–	4211
2025 Q3	$7.22K	Hold	255	–	–	﹤0.01%	3018
2025 Q2	$4.78K	Hold	255	–	–	﹤0.01%	3038
2025 Q1	$4.59K	Hold	255	–	–	﹤0.01%	2973
2024 Q4	$4.29K	Hold	255	–	–	﹤0.01%	2989
2024 Q3	$4.13K	Hold	255	–	–	﹤0.01%	2950
2024 Q2	$2.1K	Hold	255	–	–	﹤0.01%	3089
2024 Q1	$3.77K	Hold	255	–	–	﹤0.01%	2916
2023 Q4	$3.7K	Hold	255	–	–	﹤0.01%	2947
2023 Q3	$2.75K	Hold	255	–	–	﹤0.01%	2901
2023 Q2	$3.29K	Hold	255	–	–	﹤0.01%	2888
2023 Q1	$3.37K	Hold	255	–	–	﹤0.01%	2852
2022 Q4	$3.83K	Hold	255	–	–	﹤0.01%	2797
2022 Q3	$3K	Hold	255	–	–	﹤0.01%	2813
2022 Q2	$3K	Hold	255	–	–	﹤0.01%	2857
2022 Q1	$8K	Hold	255	–	–	﹤0.01%	2609
2021 Q4	$7K	Hold	255	–	–	﹤0.01%	2687
2021 Q3	$9K	Hold	255	–	–	﹤0.01%	2507
2021 Q2	$11K	Hold	255	–	–	﹤0.01%	2400
2021 Q1	$9K	Hold	255	–	–	﹤0.01%	2316
2020 Q4	$9K	Hold	255	–	–	﹤0.01%	2228
2020 Q3	$6K	Hold	255	–	–	﹤0.01%	2138
2020 Q2	$5K	Hold	255	–	–	﹤0.01%	2075
2020 Q1	$4K	Hold	255	–	–	﹤0.01%	2124
2019 Q4	$5K	Hold	255	–	–	﹤0.01%	2081
2019 Q3	$5K	Hold	255	–	–	﹤0.01%	2108
2019 Q2	$7K	Hold	255	–	–	﹤0.01%	2057
2019 Q1	$7K	Buy	+255	New	+$5.83K	﹤0.01%	2059

Other funds holding RIGL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northwestern Mutual Wealth Management's RIGL Position: Q4 2025 in Review

Northwestern Mutual Wealth Management sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 255 shares — an estimated $7.22K sold.

Northwestern Mutual Wealth Management first reported a position in RIGL in Q1 2019 and held it in 27 quarters. The position peaked at $11K in Q2 2021. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

Northwestern Mutual Wealth Management reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 255 Rigel Pharmaceuticals shares in Q4 2025, an estimated $7.22K.
Northwestern Mutual Wealth Management first reported a position in Rigel Pharmaceuticals in Q1 2019 and held it in 27 quarters.
Northwestern Mutual Wealth Management's Rigel Pharmaceuticals position peaked at $11K in Q2 2021.
193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2025, filed 5 Feb 2026.